← Back to Search

Absorbable Suture

Absorbable vs Nonabsorbable Sutures for Cuts

N/A
Recruiting
Led By Brian Chinnock, MD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patient 18-years or older
Single laceration on trunk or extremity requiring suture closure
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-month
Awards & highlights

Study Summary

This trial will compare the outcomes of using Vicryl Rapide suture to nonabsorbable suture for repairing lacerations on the trunk or extremities of adults.

Who is the study for?
Adults over 18 with a single laceration longer than 2 cm on the trunk or extremity that can be closed with simple stitches. Excluded are those with wound healing issues, mental incapacity to consent, non-English/Spanish speakers, no reliable contact info, multiple lacerations needing sutures in the same area, and wounds at high risk of infection or poor healing.Check my eligibility
What is being tested?
The trial is testing if Vicryl Rapide (an absorbable suture) is as good for stitching up skin cuts on body/extremities as nonabsorbable sutures. It's a controlled study where patients are randomly chosen to get one type of stitch and then checked after three months.See study design
What are the potential side effects?
Potential side effects may include typical risks associated with suturing such as infection, allergic reactions to the material used in Vicryl Rapide sutures, pain at the site of closure, scarring differences between suture types.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I have a single cut on my body or limb that needs stitches.
Select...
My wound will be closed with basic stitching.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The two treatments will be compared by a noninferiority test
Secondary outcome measures
Percentage of patients needing further treatment

Trial Design

2Treatment groups
Active Control
Group I: AbsorbableActive Control1 Intervention
Wound repaired with Vicryl Rapide absorbable suture
Group II: NonabsorbableActive Control1 Intervention
Wound repaired with traditional nonabsorbable suture

Find a Location

Who is running the clinical trial?

Central California Faculty Medical GroupOTHER
2 Previous Clinical Trials
547 Total Patients Enrolled
University of California, San FranciscoLead Sponsor
2,512 Previous Clinical Trials
15,244,363 Total Patients Enrolled
Brian Chinnock, MDPrincipal InvestigatorUniversity of California, San Francisco
3 Previous Clinical Trials
929 Total Patients Enrolled

Media Library

Vicryl Rapide (Absorbable Suture) Clinical Trial Eligibility Overview. Trial Name: NCT04056013 — N/A
Traumatic Lacerations Research Study Groups: Absorbable, Nonabsorbable
Traumatic Lacerations Clinical Trial 2023: Vicryl Rapide Highlights & Side Effects. Trial Name: NCT04056013 — N/A
Vicryl Rapide (Absorbable Suture) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04056013 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are applications still being received for this research endeavor?

"Affirmative. According to records available on clinicaltrials.gov, this investigation was published on September 26th 2019 and is currently looking for 96 volunteers from 2 locations. It has been recently updated as of March 28th 2022."

Answered by AI

What is the cap on participants for this clinical research?

"Affirmative. According to clinicaltrials.gov, this clinical trial is currently enrolling subjects for participation. It was first posted on September 26th 2019 and the most recent update happened on March 28th 2022; 96 patients are needed between two sites in total."

Answered by AI
~20 spots leftby Sep 2025